CervoMed (NASDAQ:CRVO) Stock Rating Upgraded by Chardan Capital
CervoMed (NASDAQ:CRVO – Get Free Report) was upgraded by investment analysts at Chardan Capital to a “strong-buy” rating in a report released on Monday,Zacks.com reports. A number of other research firms have also commented on CRVO. HC Wainwright restated a “buy” rating on shares of CervoMed in a research report on Wednesday, July 15th. Roth […]
6 Aug 08:36 · The Cerbat Gem